| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5K | +0.0% |
| Gross Profit | $5K | +0.0% |
| R&D Expense | $8K | -21.3% |
| SG&A Expense | $435K | +17.0% |
| Operating Income | -$435K | -18.6% |
| Pre-tax Income | -$292K | -173.5% |
| Net Income | -$292K | -173.5% |
| EPS (Basic) | -$0.00 | -167.4% |
| EPS (Diluted) | -$0.00 | -168.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12K | +11.1% |
| Current Assets | $146K | +761.0% |
| Total Assets | $433.8M | +0.4% |
| Current Liabilities | $5.0M | +0.3% |
| Total Liabilities | $5.1M | -2.2% |
| Stockholders' Equity | $428.8M | +0.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$306K | +19.0% |
| Capital Expenditures | $12K | — |
| Investing Cash Flow | -$12K | — |
| Financing Cash Flow | $319K | -16.3% |
| Free Cash Flow | -$318K | — |